Literature DB >> 7636435

Epidermal growth factor stimulates cell proliferation and inhibits iodide uptake of FRTL-5 cells in vitro.

L M Asmis1, H Gerber, J Kaempf, H Studer.   

Abstract

In accordance with the available data most authors conclude that epidermal growth factor (EGF) has very little or no effect on FRTL-5 cells. This has been viewed as a serious handicap of this cell line. In the present study we cultivated three strains of FRTL-5 cells from different sources and assessed their response to EGF with regard to proliferation, function and differentiation. Cell proliferation was assessed by counting in a Coulter cell counter after culturing cells at suboptimal conditions in well plates. Cell function was studied by measuring iodide uptake. Cell differentiation was examined immunocytochemically by staining monolayer cultures for thyroglobulin (Tg) and EGF receptor (EGFr) as well as morphologically by microscopical evaluation of monolayer cultures. All three FRTL-5 cell lines investigated express EGFr. In two wild type FRTL-5 cell lines EGF stimulates growth, an effect that is enhanced by the presence of TSH, and partially inhibits iodide uptake. A third mutated strain of FRTL-5 cells does not respond to EGF. Tg expression can be demonstrated immunocytochemically in EGF-treated cells as well as in controls. Morphologically, in monolayer culture EGF-treated cells cannot be distinguished from controls. Contrary to previous reports, these studies demonstrate EGF effects on FRTL-5 cells that are consistent with EGF effects established in other thyroid follicular cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636435     DOI: 10.1677/joe.0.1450513

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.

Authors:  Hong-Ming Song; Yi Luo; Deng-Feng Li; Chuan-Kui Wei; Kai-Yao Hua; Jia-Lu Song; Hui Xu; Niraj Maskey; Lin Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.

Authors:  S Hoffmann; K Maschuw; I Hassan; A Wunderlich; S Lingelbach; A Ramaswamy; L C Hofbauer; A Zielke
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

3.  CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells.

Authors:  Lei Cui; Qing Zhang; Zhengfa Mao; Jixiang Chen; Xuqing Wang; Jianguo Qu; Jianxin Zhang; Dayong Jin
Journal:  Tumour Biol       Date:  2011-04-20

4.  EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells.

Authors:  Wang Xuqing; Cui Lei; Mao Zhengfa; Dang Shengchun; Fan Xin; Qu Jianguo; Zhang Jianxin
Journal:  Tumour Biol       Date:  2012-04-24

5.  Fabrication of Functional Cell Sheets with Human Thyrocytes from Non-Tumorous Thyroid Tissue.

Authors:  Yu Huang; Kosho Yamanouchi; Yusuke Sakai; Sayaka Kuba; Chika Sakimura; Michi Morita; Kengo Kanetaka; Mitsuhisa Takatsuki; Susumu Eguchi
Journal:  Tissue Eng Regen Med       Date:  2019-07-05       Impact factor: 4.169

6.  EGF and TGF-β1 Effects on Thyroid Function.

Authors:  Gabriella Mincione; Maria Carmela Di Marcantonio; Chiara Tarantelli; Sonia D'Inzeo; Arianna Nicolussi; Francesco Nardi; Caterina Francesca Donini; Anna Coppa
Journal:  J Thyroid Res       Date:  2011-06-13

7.  Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity.

Authors:  Daniela Melnik; Jayashree Sahana; Thomas J Corydon; Sascha Kopp; Mohamed Zakaria Nassef; Markus Wehland; Manfred Infanger; Daniela Grimm; Marcus Krüger
Journal:  Cells       Date:  2020-02-05       Impact factor: 6.600

Review 8.  Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.

Authors:  G C Hard
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.